公司资料
Centessa Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- CNTA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom
股票表现
40.50 USD (+0.80%)
收盘价
最后更新: 2026年6月23日
6.17B USD
市值
股价为何变动
Current closing-price context is not available for CNTA.
公司概览
业务概览
Centessa Pharmaceuticals is a platform biopharma company incubating focused therapeutic programs across multiple disease areas. Its model emphasizes capital allocation, program selection, and broad platform optionality.
所在地与行业分类
Headquartered in the United Kingdom and listed on NASDAQ as an ADR, Centessa has a global specialty-biopharma profile.
商业模式特征
The company depends on pipeline prioritization, clinical validation, and the ability to unlock value from multiple programs.
生物医药行业定位
Centessa is a platform biotech name whose valuation reflects optionality and execution across a portfolio of assets.
未来催化剂
- Centessa’s catalyst set is ORX750 and the broader orexin-agonist strategy, which could matter a lot if the sleep program continues to show a clean dose and efficacy profile. The next update is important because the market wants to know whether the orexin thesis can become a real franchise.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。